Impact of ESSURE Devices Withdrawal on the Symptomatology of Patients
Status
Conditions
Treatments
Details and patient eligibility
About
The ESSURE device is a method of permanent contraception, marketed in France since 2005. Multiple side effects have been reported by patients since 2015 and the marketing was stopped in 2017. For several months it was observed an increase in requests for withdrawal of these devices. The principal objective of this study is to evaluate clinical improvement and quality of life after ESSURE removal.
This is a multicenter retrospective descriptive study involving the gynecology department of the Croix Rousse Hospital and the gynecology department of the Lyon Sud Hospital over a period of 1 year (1 January 2017-31 December 2017).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Women who underwent ESSURE removal due to suspected adverse effects of the device.
- Women who agreed to participate in the study
Exclusion criteria
- Women who underwent ESSURE removal to restore their fertility.
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal